LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

3 result(s)
Filter and sort
3 result(s)
Journal Article > ResearchFull Text

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India

PLOS One. 26 September 2014; Volume 9 (Issue 9); DOI:10.1371/journal.pone.0108186
Das M, Isaakidis P, Shenoy R, Anicete R, Sharma H,  et al.
PLOS One. 26 September 2014; Volume 9 (Issue 9); DOI:10.1371/journal.pone.0108186
Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-east India have poor access to health services. Our study aimed to detail treatment outcomes in TB program supported by Médecins Sans Frontières (MSF) and using an alternative model of TB treatment delivery in Mon district, Nagaland, India.More
Journal Article > ResearchFull Text

Paragonimiasis in Tuberculosis Patients in Nagaland, India

Glob Health Action. 23 September 2016
Das M, Doleckova K, Shenoy R, Mahanta J, Narain K,  et al.
Glob Health Action. 23 September 2016
One of the infections that mimic tuberculosis (TB) is paragonimiasis (PRG), a foodborne parasitic disease caused by lung flukes of the genus Paragonimus. In the northeastern states of India, TB and PRG are endemic; however, PRG is rarely included in the differential diagnosis of TB.More
Journal Article > ResearchFull Text

Double trouble: tuberculosis and substance abuse in Nagaland, India

Public Health Action. 21 September 2015; Volume 5 (Issue 3); 180-2.; DOI:10.5588/pha.15.0019
Shenoy R, Das M, Mansoor H, Anicete R, Wangshu L,  et al.
Public Health Action. 21 September 2015; Volume 5 (Issue 3); 180-2.; DOI:10.5588/pha.15.0019
The diagnosis and treatment of tuberculosis (TB) in people who use and/or inject illicit drugs (PWUIDs) remains a barrier to achieving universal coverage for TB in India and globally. This report describes treatment outcomes in PWUIDs who received treatment for drug-susceptible TB at the Mon District Hospital in Nagaland, India, during 2012-2013. The median age of the patients was 39 years, and most (92%) were male. Two thirds (33/49) of the patients had a successful TB treatment outcome. A previous TB episode and residence in a semi-urban area were associated with unsuccessful treatment outcomes. Separate diagnostic and treatment algorithms, including regular adherence counselling and opioid substitution therapies, should be considered for PWUIDs.More